Barclays PLC lessened its holdings in Agilent Technologies, Inc. (NYSE:A - Free Report) by 17.8% in the 4th quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 619,571 shares of the medical research company's stock after selling 134,166 shares during the period. Barclays PLC owned approximately 0.22% of Agilent Technologies worth $83,232,000 at the end of the most recent quarter.
Other institutional investors have also bought and sold shares of the company. Wellington Management Group LLP increased its stake in Agilent Technologies by 0.6% in the fourth quarter. Wellington Management Group LLP now owns 9,306,805 shares of the medical research company's stock valued at $1,250,276,000 after purchasing an additional 59,781 shares in the last quarter. Geode Capital Management LLC boosted its holdings in shares of Agilent Technologies by 0.8% in the 4th quarter. Geode Capital Management LLC now owns 7,002,671 shares of the medical research company's stock valued at $938,291,000 after buying an additional 53,992 shares during the last quarter. Pictet Asset Management Holding SA increased its stake in shares of Agilent Technologies by 0.9% during the 4th quarter. Pictet Asset Management Holding SA now owns 5,213,739 shares of the medical research company's stock worth $700,414,000 after purchasing an additional 47,495 shares during the last quarter. Norges Bank acquired a new stake in shares of Agilent Technologies in the fourth quarter valued at approximately $456,963,000. Finally, Cantillon Capital Management LLC increased its holdings in shares of Agilent Technologies by 0.5% in the fourth quarter. Cantillon Capital Management LLC now owns 3,316,557 shares of the medical research company's stock valued at $445,546,000 after purchasing an additional 17,627 shares during the last quarter.
Analyst Ratings Changes
Several brokerages have weighed in on A. TD Cowen lifted their price objective on shares of Agilent Technologies to $135.00 and gave the stock a "buy" rating in a research note on Thursday, April 10th. Robert W. Baird dropped their target price on Agilent Technologies from $161.00 to $159.00 and set an "outperform" rating for the company in a research report on Thursday, February 27th. Wells Fargo & Company lowered their target price on Agilent Technologies from $155.00 to $135.00 and set an "overweight" rating for the company in a research report on Thursday. StockNews.com upgraded Agilent Technologies from a "hold" rating to a "buy" rating in a report on Tuesday, December 24th. Finally, Barclays decreased their price objective on Agilent Technologies from $138.00 to $115.00 and set an "equal weight" rating for the company in a report on Thursday, April 10th. Seven investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company's stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $144.58.
Read Our Latest Stock Report on A
Agilent Technologies Price Performance
Shares of NYSE:A traded down $2.42 during trading on Monday, hitting $100.06. 346,873 shares of the company's stock were exchanged, compared to its average volume of 2,053,483. The business's 50-day simple moving average is $119.55 and its 200 day simple moving average is $132.31. Agilent Technologies, Inc. has a 52-week low of $96.43 and a 52-week high of $155.35. The company has a market cap of $28.53 billion, a price-to-earnings ratio of 23.00, a PEG ratio of 2.89 and a beta of 1.19. The company has a debt-to-equity ratio of 0.56, a current ratio of 2.20 and a quick ratio of 1.66.
Agilent Technologies (NYSE:A - Get Free Report) last announced its quarterly earnings data on Wednesday, February 26th. The medical research company reported $1.31 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.27 by $0.04. The business had revenue of $1.68 billion during the quarter, compared to the consensus estimate of $1.67 billion. Agilent Technologies had a net margin of 19.27% and a return on equity of 25.56%. As a group, equities analysts predict that Agilent Technologies, Inc. will post 5.54 EPS for the current year.
Agilent Technologies Announces Dividend
The business also recently declared a quarterly dividend, which will be paid on Wednesday, April 23rd. Investors of record on Tuesday, April 1st will be given a dividend of $0.248 per share. This represents a $0.99 annualized dividend and a yield of 0.99%. The ex-dividend date is Tuesday, April 1st. Agilent Technologies's dividend payout ratio is currently 22.76%.
Insider Activity at Agilent Technologies
In other news, Director Daniel K. Podolsky sold 1,819 shares of the business's stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $116.46, for a total value of $211,840.74. Following the transaction, the director now owns 35,737 shares of the company's stock, valued at approximately $4,161,931.02. The trade was a 4.84 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, VP Rodney Gonsalves sold 1,908 shares of the stock in a transaction that occurred on Monday, March 17th. The stock was sold at an average price of $121.98, for a total value of $232,737.84. Following the transaction, the vice president now directly owns 21,786 shares of the company's stock, valued at approximately $2,657,456.28. This trade represents a 8.05 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last quarter, insiders have sold 5,638 shares of company stock worth $731,229.
Agilent Technologies Profile
(
Free Report)
Agilent Technologies, Inc provides application focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide. The company operates in three segments: Life Sciences and Applied Markets, Diagnostics and Genomics, and Agilent CrossLab. The Life Sciences and Applied Markets segment offers liquid chromatography systems and components; liquid chromatography mass spectrometry systems; gas chromatography systems and components; gas chromatography mass spectrometry systems; inductively coupled plasma mass spectrometry instruments; atomic absorption instruments; microwave plasma-atomic emission spectrometry instruments; inductively coupled plasma optical emission spectrometry instruments; raman spectroscopy; cell analysis plate based assays; flow cytometer; real-time cell analyzer; cell imaging systems; microplate reader; laboratory software; information management and analytics; laboratory automation and robotic systems; dissolution testing; and vacuum pumps, and measurement technologies.
Read More
Before you consider Agilent Technologies, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Agilent Technologies wasn't on the list.
While Agilent Technologies currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Thinking about investing in Meta, Roblox, or Unity? Enter your email to learn what streetwise investors need to know about the metaverse and public markets before making an investment.
Get This Free Report
